Sun Pharmaceutical Industries Ltd.

Equities

SUNPHARMA

INE044A01036

Delayed NSE India S.E. Other stock markets 04:21:02 2026-01-20 am EST			5-day change	1st Jan Change
1,614.50 ^INR	-3.63%		-7.09%	-6.20%

Jan. 19	Sun Pharma states Organon acquisition news is speculative	RE
Jan. 15	Sun Pharmaceutical Industries Limited Announces the Availability of UNLOXCYT (cosibelimab-ipdl) for Advanced Cutaneous Squamous Cell Carcinoma	CI

Transcript : Sun Pharmaceutical Industries Limited, Q2 2026 Earnings Call, Nov 05, 2025

Published on 11/05/2025 at 10:21 am EST - Modified on 11/05/2025 at 04:07 pm EST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Ladies and gentlemen, good day, and welcome to Sun Pharma's Q2 FY '26 Earnings Conference Call. [Operator Instructions].

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Sun Pharmaceutical Industries Ltd.

Jan. 19	Sun Pharma states Organon acquisition news is speculative	RE
Jan. 15	Sun Pharmaceutical Industries Limited Announces the Availability of UNLOXCYT (cosibelimab-ipdl) for Advanced Cutaneous Squamous Cell Carcinoma	CI
Jan. 07	Sun Pharma Canada Inc. Announces Availability Of ILUMYA Pen For Moderate-To-Severe Plaque Psoriasis	CI
Dec. 23	Lilly, Novo lock horns in India's obesity drug race	RE
Dec. 18	Indian Equities Post Marginal Loss on Thursday as Consolidation Continues	MT
Dec. 17	Sun Pharmaceutical's Baska Facility Receives 'Official Action Indicated' Status From US FDA	MT
Dec. 17	Sun Pharma says US FDA determines Baska facility inspection classification as OAI	RE
Dec. 12	Indian Stocks Extend Gains on Friday as Global Sentiment Improves After US Rate Cut	MT
Dec. 12	Ozempic launches in India at $24 a week as Novo targets booming diabetes market	RE
Dec. 03	Novo Nordisk gears up for December Ozempic launch in India, sources say	RE
Dec. 01	Sun Pharmaceutical Launches Plaque Psoriasis Drug in India	MT
Nov. 30	Sun Pharma introduces Ilumya in India	RE
Nov. 30	Sun Pharma Introduces Its Global Innovative Drug, Ilumya in India for Treatment of Moderate-To-Severe Plaque Psoriasis	CI
Nov. 28	Indian Equities Ended Flat on Friday Ahead of Q2 GDP Data	MT
Nov. 26	Sun Pharma says FDA approves label update for Unloxcyt	RE
Nov. 25	Sun Pharmaceutical Industries Limited Announces Updated Label for Unloxcyt?	CI
Nov. 17	AstraZeneca Pharma India, Sun Pharma Sign Second Brand Deal for SZC in India	MT
Nov. 17	Astrazeneca Pharma India and Sun Pharma partner for hyperkalaemia treatment	RE
Nov. 17	AstraZeneca Pharma India Limited and Sun Pharmaceutical Industries Limited Announce Partnership to Help Patients Living with Hyperkalaemia in India	CI
Nov. 12	Sun Pharma presents data from phase 1b/2a study of GL0034	RE
Nov. 12	Sun Pharma says once weekly utregrlutide dosing for ten weeks showed body weight loss of 6.8%	RE
Nov. 12	Sun Pharmaceutical Industries Limited Presents Data from Phase 1b/2a Study of GL0034 at the American Heart Association 2025 Scientific Sessions	CI
Nov. 07	India's Torrent Pharma posts profit boost on strong demand for chronic illness drugs	RE
Nov. 07	Nomura Upgrades Sun Pharmaceutical Industries to Buy From Neutral, Adjusts Price Target to INR1,960 From INR1,910	MT
Nov. 06	Sun Pharmaceutical's Consolidated Net Profit Rises in Fiscal Q2	MT